124 related articles for article (PubMed ID: 15646821)
1. Clinical concentrations of thioridazine enhance the killing of intracellular methicillin-resistant Staphylococcus aureus: an in vivo, ex vivo and electron microscopy study.
Martins M; Bleiss W; Marko A; Ordway D; Viveiros M; Leandro C; Pacheco T; Molnar J; Kristiansen JE; Amaral L
In Vivo; 2004; 18(6):787-94. PubMed ID: 15646821
[TBL] [Abstract][Full Text] [Related]
2. Thioridazine reduces resistance of methicillin-resistant staphylococcus aureus by inhibiting a reserpine-sensitive efflux pump.
Kristiansen MM; Leandro C; Ordway D; Martins M; Viveiros M; Pacheco T; Molnar J; Kristiansen JE; Amaral L
In Vivo; 2006; 20(3):361-6. PubMed ID: 16724671
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609
[TBL] [Abstract][Full Text] [Related]
4. Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis.
Ordway D; Viveiros M; Leandro C; Bettencourt R; Almeida J; Martins M; Kristiansen JE; Molnar J; Amaral L
Antimicrob Agents Chemother; 2003 Mar; 47(3):917-22. PubMed ID: 12604522
[TBL] [Abstract][Full Text] [Related]
5. Intracellular activity of clinical concentrations of phenothiazines including thioridiazine against phagocytosed Staphylococcus aureus.
Ordway D; Viveiros M; Leandro C; Arroz MJ; Amaral L
Int J Antimicrob Agents; 2002 Jul; 20(1):34-43. PubMed ID: 12127709
[TBL] [Abstract][Full Text] [Related]
6. Chlorpromazine has intracellular killing activity against phagocytosed Staphylococcus aureus at clinical concentrations.
Ordway D; Viveiros M; Leandro C; Jorge Arroz M; Molnar J; Kristiansen JE; Amaral L
J Infect Chemother; 2002 Sep; 8(3):227-31. PubMed ID: 12373485
[TBL] [Abstract][Full Text] [Related]
7. In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis.
Martins M; Schelz Z; Martins A; Molnar J; Hajös G; Riedl Z; Viveiros M; Yalcin I; Aki-Sener E; Amaral L
Int J Antimicrob Agents; 2007 Mar; 29(3):338-40. PubMed ID: 17239569
[TBL] [Abstract][Full Text] [Related]
8. Reversing methicillin resistance in MRSA using a bacterial transforming agent.
Carey BE; Dancer SJ
J Antimicrob Chemother; 2006 Aug; 58(2):455-7. PubMed ID: 16787954
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo activities of echinomycin against clinical isolates of Staphylococcus aureus.
Park YS; Shin WS; Kim SK
J Antimicrob Chemother; 2008 Jan; 61(1):163-8. PubMed ID: 17967852
[TBL] [Abstract][Full Text] [Related]
10. Effect of Saliva miltiorrhiza bunge on antimicrobial activity and resistant gene regulation against methicillin-resistant Staphylococcus aureus (MRSA).
Lee JW; Ji YJ; Lee SO; Lee IS
J Microbiol; 2007 Aug; 45(4):350-7. PubMed ID: 17846590
[TBL] [Abstract][Full Text] [Related]
11. [Prevalence of Staphylococcus aureus methicillin-resistant (MRSA) among health care workers].
Fenga C; Foti M; Daidone A; Sturniolo G; Maviglia P; Di Nola C; Polito I; Mondello P
G Ital Med Lav Ergon; 2007; 29(3 Suppl):416-7. PubMed ID: 18409753
[TBL] [Abstract][Full Text] [Related]
12. Prolonged exposure of methicillin-resistant Staphylococcus aureus (MRSA) COL strain to increasing concentrations of oxacillin results in a multidrug-resistant phenotype.
Martins A; Couto I; Aagaard L; Martins M; Viveiros M; Kristiansen JE; Amaral L
Int J Antimicrob Agents; 2007 Mar; 29(3):302-5. PubMed ID: 17276037
[TBL] [Abstract][Full Text] [Related]
13. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients.
Skiest DJ; Brown K; Cooper TW; Hoffman-Roberts H; Mussa HR; Elliott AC
J Infect; 2007 May; 54(5):427-34. PubMed ID: 17070598
[TBL] [Abstract][Full Text] [Related]
14. Synergic interaction between pomegranate extract and antibiotics against Staphylococcus aureus.
Braga LC; Leite AA; Xavier KG; Takahashi JA; Bemquerer MP; Chartone-Souza E; Nascimento AM
Can J Microbiol; 2005 Jul; 51(7):541-7. PubMed ID: 16175202
[TBL] [Abstract][Full Text] [Related]
15. Quercus infectoria: a candidate for the control of methicillin-resistant Staphylococcus aureus infections.
Chusri S; Voravuthikunchai SP
Phytother Res; 2008 Apr; 22(4):560-2. PubMed ID: 18338770
[TBL] [Abstract][Full Text] [Related]
16. In vitro pharmacodynamics of novel rifamycin ABI-0043 against Staphylococcus aureus.
Tsuji BT; Yang JC; Forrest A; Kelchlin PA; Smith PF
J Antimicrob Chemother; 2008 Jul; 62(1):156-60. PubMed ID: 18400804
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
Garrison MW; Nuemiller JJ
Int J Antimicrob Agents; 2007 Feb; 29(2):191-6. PubMed ID: 17174074
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial therapy of multidrug-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and methicillin-resistant Staphylococcus aureus.
Cunha BA
Med Clin North Am; 2006 Nov; 90(6):1165-82. PubMed ID: 17116442
[TBL] [Abstract][Full Text] [Related]
19. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.
Sakoulas G; Gold HS; Cohen RA; Venkataraman L; Moellering RC; Eliopoulos GM
J Antimicrob Chemother; 2006 Apr; 57(4):699-704. PubMed ID: 16464892
[TBL] [Abstract][Full Text] [Related]
20. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation.
Miller LG; Perdreau-Remington F; Bayer AS; Diep B; Tan N; Bharadwa K; Tsui J; Perlroth J; Shay A; Tagudar G; Ibebuogu U; Spellberg B
Clin Infect Dis; 2007 Feb; 44(4):471-82. PubMed ID: 17243048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
